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Mortality by laterality of the primary tumour among 55,000 breast
cancer patients from the Swedish Cancer Registry
L.E. Rutqvist & H. Johansson
Oncologic Centre, Radiumhemmet, Karolinska Hospital, S-104 01 Stockholm, Sweden.
Summary To examine the hypothesis that radiotherapy for breast cancer can cause myocardial infarction,
cause-specific mortality by laterality of the primary tumour was analysed among 54,617 breast cancer patients
reported to the Swedish Cancer Registry during 1970-1985. The rationale was that radiotherapy for a
left-sided breast cancer invariably results in higher doses of radiation to the myocardium than a similar
treatment given for a right-sided tumour whereas other possible risk factors for cardiovascular disease
probably are unrelated to the laterality of the tumour. The median follow-up was 9 years (range 1-17 years).
Patients with left-sided tumours were found to have a higher mortality due to myocardial infarction than
patients with right-sided tumours (P<0.01) but there was no difference in regard to total intercurrent
mortality. Further analyses of individual radiotherapy studies are warranted to quantify the excess risk
associated with radiation and to study the significance of the type of radiation, portal arrangements, total dose
and fractionation. It seems reasonable to assume that adverse effects of radiation are dose-related and may
thus be minimised or prevented by the use of appropriate treatment techniques.
Two overviews of trials of postoperative radiotherapy in
early breast cancer suggested a detrimental effect of radiation
on long-term survival (Cuzick et al., 1987a,b). Analyses of
cause-specific mortality in individual radiotherapy studies
have indicated that this observation may have been due to an
increase of cardiovascular deaths as a result of radiation-
induced damage to the myocardium (Host et al., 1986;
Haybittle et al., 1988; Jones & Ribeiro, 1988).
This paper presents data on intercurrent mortality by
laterality of the primary tumour among breast cancer
patients reported to the Swedish Cancer Registry during
1970-1985. The registry does not record information on
treatment but previous population-based surveys in Sweden
have shown that about 50% of all breast cancer patients
during the mentioned period received radiotherapy as part of
their primary therapy (L.E. Rutqvist, unpublished data).
Radiotherapy for a left-sided breast cancer invariably results
in higher doses of radiation to the myocardium than a
similar treatment given for a right-sided tumour. Therefore,
it seems reasonable to assume that any difference in mortality
between patients with left-sided compared with right-sided
tumours can be attributed to radiation. Other possible risk
factors for cardiovascular disease, such as genetic predisposi-
tion, smoking and dietary habits, are probably unrelated to
the laterality of a primary breast cancer. The aim of the
study was thus to examine the hypothesis that radiotherapy
for breast cancer can cause cardiovascular death, notably
myocardial infarction, through a direct effect of radiation on
the myocardium.
Materials and methods
Laterality of breast cancer was not recorded in the Swedish
Cancer Registry before 1970. The study was therefore based
on cases diagnosed during 1970-1985. A total of 64,200
cases were reported to the registry during the mentioned
period of whom 2,604 (4%) were excluded from this study
because of incomplete identification, a diagnosis of breast
cancer that was made first at autopsy, or because data on
laterality were unavailable. The remaining 61,596 patients
were matched to the Swedish Registry of Causes-of-Death by
computerised record linkage using the personal identification
number (ID-number) which is unique to all persons living in
Sweden.
The Cancer Registry records multiple primary tumours
occurring in a single patient as separate cases. Women with
bilateral breast cancer are thus recorded as two cases. Multi-
ple tumours are sequentially numbered and can be assigned
to the individual host by use of the ID-number. For reasons
of data integrity, ID-numbers were not available on the data
file from the Cancer Registry which made it impossible in
this study to distinguish between patients with bilateral
breast cancer and patients with other multiple tumours.
Therefore, the analyses were restricted to those 54,617
patients (89%) in whom the sequential tumour number
indicated that patient did not have any previous cancer.
The certified underlying cause was available for deaths
during 1970-1986 giving a median follow-up of 9 years
(range 1-17 years). The end-points used for evaluation were
death due to all causes, all intercurrent causes, all cardiovas-
cular diseases, and myocardial infarction.
Log rank comparisons were made of time from diagnosis
of breast cancer to the mentioned end-points by laterality of
the tumour (Peto et al., 1976, 1977). The relative risk (RR)
for patients with left-sided tumours compared to those with
right-sided tumours was calculated according to Haybittle
(1979). Time trends in the relative risks were analysed with a
test for trend as described by Breslow (1984).
Results
During follow-up there was a total of 25,039 deaths. The
life-table estimate of observed survival at 5, 10 and 15 years
for the total material was 65 ± 0.3% (standard error),
45 ± 0.3% and 33 ± 0.4%. The number of deaths due to all
intercurrent causes, cardiovascular disease, and myocardial
infarction was 9,297, 5,851 and 3,369 respectively.
There was no difference between patients with left-sided
tumours compared to those with right-sided tumours in
regard to total mortality, total intercurrent mortality or total
cardiovascualr mortality (Table I). However, the number of
deaths due to myocardial infarction was significantly higher
among patients with left-sided tumours with a RR of 1.09
(95% confidence interval 1.02-1.17).
The RR (left-sided versus right-sided tumours) for all men-
tioned types of deaths appeared to increase with time but the
trend tests were not statistically significant (Table I). For
instance, the RR of death due to myocardial infarction was
1.06 during 0-5 years after primary diagnosis, 1.13 during
5-10 years and 1.20 during 10-17 years (P = 0.22).
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Discussion
This study confirms previous reports suggesting that
radiotherapy for breast cancer can cause myocardial infarc-
tion. For instance, in the British Cancer Research Campaign
(CRC) trial the RR for cardiac death after 5 years associated
with radiation was 1.65 (95% confidence interval 1.05-2.59)
(Haybittle et al., 1988). The RR for patients with left-sided
tumours was substantially higher (2.26) than for patients
with right-sided tumours (1.20). Also, the RR associated with
orthovoltage radiation appeared to be higher (1.86) than with
megavoltage techniques (1.27).
In this study there was an excess risk of death due to
myocardial infarction for patients with left-sided tumours
during the entire follow-up period and the risk appeared to
increase with time. Our figures probably represent a conser--
vative estimate of the risk associated with radiation per se
because all patients included in the study did not receive
radiotherapy. Moreover, the myocardium receives some
radiation also in patients treated for right-sided tumours but
the clinical significance of such relatively small doses remains
controversial. In the Manchester trials no significant excess
risk of cardiac death was observed with radiation in patients
with right-sided tumours (Jones & Ribeiro, 1988) whereas in
the mentioned CRC trial the risk appeared to be slightly
increased after 5 years (RR: 1.20).
Previous population-based surveys in Sweden have shown
that about 50% of all breast cancer patients during the 1970s
and early 1980s received radiotherapy as part of their
primary therapy, usually with supervoltage techniques (L.E.
Rutqvist, unpublished data). Under the assumption that only
half of the patients included in this study received
radiotherapy, the RR of cardiac death (left-sided versus
right-sided tumours) associated with radiation can be
estimated as 1.2 Similar estimates for the different periods of
follow-up were 1.1 (0-5 years), 1.3 (5-10 years) and 1.4
(10-17 years). These estimates are thus similar to the results
for supervoltage radiation in the CRC trial, i.e. a RR for
cardiac death after 5 years of 1.27 (all tumours) or 1.35
(left-sided tumours).
Further analyses of individual radiotherapy trials are war-
ranted to quantify the risk associated with radiotherapy,
particularly supervoltage radiation, since orthovoltage techni-
ques are no longer used for adjuvant treatment of early
disease. Such analyses should also address the significance of
portal arrangements, total dose and fractionation because
different techniques may result in substantial differences in
the biological dose of radiation to the myocardium. It seems
reasonable to assume that adverse effects are dose-related
and may thus be minimised or prevented by the use of
appropriate treatment techniques.
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